Health first, maximize the development of cutting-edge products; respect employees, let employees and the company grow together; balanced development, the pursuit of maximum value of the company.
Our company is market-oriented, committed to providing customers with reliable and advanced early diagnosis reagents for cancer and malignant tumors and targeted drug delivery system for chemotherapy drugs, so as to meet the needs of early diagnosis and targeted treatment for cancer and malignant tumor patients, revitalize the national biological medicine industry, generate income for the country and enterprises, and benefit mankind.
With innovation serving the country and material innovation as its own responsibility, we should develop the pharmaceutical industry based on new materials and new technologies, establish a trustworthy and reputable brand image, and promote the rapid development of cancer and malignant tumor early diagnosis and targeted treatment technology.
We should adhere to independent scientific and technological innovation, develop the national biomedical industry, and take the leading technology, products and management as our own responsibilities.
The company is an innovator and pioneer in the combination of nanobiology and medicine in the world, a breakthrough and subversion in traditional cancer diagnosis and treatment, and a series of products to solve the problems of early diagnosis and targeted treatment for cancer and malignant tumor patients, and strive to become the world's strongest nano tumor targeted medicine technology provider.